Literature DB >> 12459151

An improved method of evaluation of drug-evoked changes in gastric emptying in mice.

M A Osinski1, T R Seifert, B F Cox, G A Gintant.   

Abstract

INTRODUCTION: The increased availability of transgenic mice prompts a need for the adaptation to mice of whole-animal assays traditionally performed in larger laboratory animals. Gastric emptying studies are frequently conducted in dogs and rats. Mouse-based gastric emptying models currently available often use inert, nonnutrient liquid meals containing nonabsorbable markers or radionuclides. We have developed a mouse gastric emptying assay that features a favorable throughput and the use of a semisolid, high-calorie meal.
METHODS: A carbohydrate- and protein-rich semisolid test meal was prepared from common laboratory reagents. Gastric emptying was determined by subtracting the mass of test meal remaining in the stomach from the mass of test meal administered. A time-course study of basal emptying of a semisolid, paste-like test meal high in carbohydrate and protein from the stomachs of overnight-fasted mice was conducted. Agents known to either inhibit (propantheline, 0.3-10 mg/kg sc; corticotropin-releasing factor [CRF], 3-100 nmol/kg ip) or accelerate (metoclopramide, 1-10 mg/kg ip; bethanechol, 1-30 mg/kg ip) gastric emptying were tested. A single time-point variation of the assay can be used for quickly screening compounds for effects on gastric emptying.
RESULTS: In time-course studies, the test meal emptied from the stomach with a half-emptying time of 30.6 min (95% CI: 27.3-34.7). The gastric emptying data were successfully modeled by a two-parameter exponential decay function. No lag phase was observed, indicating that the meal empties from the stomach as a liquid. The anticholinergic agent propantheline increased gastric half-emptying time (t(1/2)) approximately threefold, while metoclopramide decreased gastric half-emptying time approximately twofold compared to basal emptying. Single time-point screening studies correctly detected the gastrokinetic activity of bethanechol and the inhibitory effect of CRF. DISCUSSION: The mouse gastric emptying assay reported here is simple, inexpensive, and not labor-intensive. It is capable of detecting either stimulation or inhibition of gastric motor activity. This assay should prove useful for identifying drug-evoked changes in gastric emptying as well as for assessing the gastric motility effects of altered gene expression in genetically modified mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459151     DOI: 10.1016/s1056-8719(02)00217-4

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  10 in total

1.  Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents.

Authors:  Susan Ritger Crowell; Shantu G Amin; Kim A Anderson; Gowdahalli Krishnegowda; Arun K Sharma; Jolen J Soelberg; David E Williams; Richard A Corley
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-29       Impact factor: 4.219

2.  Guanosine negatively modulates the gastric motor function in mouse.

Authors:  Maria Grazia Zizzo; Flavia Mulè; Antonella Amato; Francesca Maiorana; Giuseppa Mudò; Natale Belluardo; Rosa Serio
Journal:  Purinergic Signal       Date:  2013-07-10       Impact factor: 3.765

3.  Assessment of gastric emptying in non-obese diabetic mice using a [13C]-octanoic acid breath test.

Authors:  Christopher T Creedon; Pieter-Jan Verhulst; Kyoung M Choi; Jessica E Mason; David R Linden; Joseph H Szurszewski; Simon J Gibbons; Gianrico Farrugia
Journal:  J Vis Exp       Date:  2013-03-23       Impact factor: 1.355

4.  Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro.

Authors:  T Kitazawa; B De Smet; K Verbeke; I Depoortere; T L Peeters
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

5.  Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice.

Authors:  Susan Ritger Crowell; Arun K Sharma; Shantu Amin; Jolen J Soelberg; Natalie C Sadler; Aaron T Wright; William M Baird; David E Williams; Richard A Corley
Journal:  Toxicol Sci       Date:  2013-06-06       Impact factor: 4.849

6.  Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.

Authors:  Lixin Wang; Guillaume Gourcerol; Pu-Qing Yuan; S Vincent Wu; Mulugeta Million; Muriel Larauche; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

7.  High temporal resolution gastric emptying breath tests in mice.

Authors:  K E Miller; Ž Bajzer; S S Hein; J E Phillips; S Syed; A M Wright; G Cipriani; S J Gibbons; J H Szurszewski; G Farrugia; T Ordog; D R Linden
Journal:  Neurogastroenterol Motil       Date:  2018-03-25       Impact factor: 3.598

8.  Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors.

Authors:  T Wultsch; E Painsipp; C K Thoeringer; H Herzog; G Sperk; P Holzer
Journal:  Neuroscience       Date:  2005-10-10       Impact factor: 3.590

9.  Translational potential of a mouse in vitro bioassay in predicting gastrointestinal adverse drug reactions in Phase I clinical trials.

Authors:  C Keating; L Ewart; L Grundy; J P Valentin; D Grundy
Journal:  Neurogastroenterol Motil       Date:  2014-05-11       Impact factor: 3.598

10.  Incretin-like effects of small molecule trace amine-associated receptor 1 agonists.

Authors:  Susanne Raab; Haiyan Wang; Sabine Uhles; Nadine Cole; Ruben Alvarez-Sanchez; Basil Künnecke; Christoph Ullmer; Hugues Matile; Marc Bedoucha; Roger D Norcross; Nickki Ottaway-Parker; Diego Perez-Tilve; Karin Conde Knape; Matthias H Tschöp; Marius C Hoener; Sabine Sewing
Journal:  Mol Metab       Date:  2015-11-01       Impact factor: 7.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.